Paper15530895
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs.
Walter MF and 5 others. Atherosclerosis, 2004. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs. Papers, record 15530895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15530895
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholesterol, LDL | Major topic |
| Cyclooxygenase Inhibitors | Major topic |
| Lactones | Major topic |
| Pyrazoles | Major topic |
| Sulfonamides | Major topic |
| Sulfones | Major topic |
| Animals | |
| Antioxidants | |
| Celecoxib | |
| Chromans | |
| Diclofenac | |
| Humans | |
| Ibuprofen | |
| Isoprostanes | |
| Isoxazoles | |
| Meloxicam | |
| Naproxen | |
| Oxidation-Reduction | |
| Thiazines | |
| Thiazoles | |
| Benzenesulfonamides |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38799798 | Imrecoxib: Advances in Pharmacology and Therapeutics. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/38799798 | PubMed |
| 37834442 | MicroRNA as Possible Mediators of the Synergistic Effect of Celecoxib and Glucosamine Sulfate in Human Osteoarthritic Chondrocyte Exposed to IL-1β. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834442 | PubMed |
| 35472207 | Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation. | PLoS One | 2022 | https://conductscience.org/library/papers/35472207 | PubMed |
| 34445685 | A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445685 | PubMed |
| 32821151 | Practice Advisory on the Appropriate Use of NSAIDs in Primary Care. | J Pain Res | 2020 | https://conductscience.org/library/papers/32821151 | PubMed |
| 30631366 | Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac. | Int J Rheumatol | 2018 | https://conductscience.org/library/papers/30631366 | PubMed |
| 30288088 | Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice. | J Pain Res | 2018 | https://conductscience.org/library/papers/30288088 | PubMed |
| 29020251 | Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. | Eur Heart J | 2017 | https://conductscience.org/library/papers/29020251 | PubMed |
| 27747190 | Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib. | Jundishapur J Nat Pharm Prod | 2015 | https://conductscience.org/library/papers/27747190 | PubMed |
| 27104573 | Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review. | Antioxidants (Basel) | 2016 | https://conductscience.org/library/papers/27104573 | PubMed |
| 26022804 | Phenotyping drug polypharmacology via eicosanoid profiling of blood. | J Lipid Res | 2015 | https://conductscience.org/library/papers/26022804 | PubMed |
| 25342992 | Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs. | Ther Adv Musculoskelet Dis | 2014 | https://conductscience.org/library/papers/25342992 | PubMed |
| 25199097 | Effects of repeated oral administration of pazufloxacin mesylate and meloxicam on the antioxidant status in rabbits. | J Am Assoc Lab Anim Sci | 2014 | https://conductscience.org/library/papers/25199097 | PubMed |
| 23749198 | The effects of cyclooxygenase and nitric oxide synthase inhibition on oxidative stress in isolated rat heart. | Mol Cell Biochem | 2013 | https://conductscience.org/library/papers/23749198 | PubMed |
| 23079497 | Design, synthesis and in vivo anti-inflammatory activities of 2,4-diaryl-5-4H-imidazolone derivatives. | Molecules | 2012 | https://conductscience.org/library/papers/23079497 | PubMed |
| 22187234 | Effects of combination therapy with celecoxib and doxycycline on neointimal hyperplasia and inflammatory biomarkers in coronary artery disease patients treated with bare metal stents. | Yonsei Med J | 2012 | https://conductscience.org/library/papers/22187234 | PubMed |
| 22084715 | Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review. | ISRN Pharmacol | 2011 | https://conductscience.org/library/papers/22084715 | PubMed |
| 19641861 | Cellular membranes function as a storage compartment for celecoxib. | J Mol Med (Berl) | 2009 | https://conductscience.org/library/papers/19641861 | PubMed |
| 18473007 | Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice? | Ther Clin Risk Manag | 2007 | https://conductscience.org/library/papers/18473007 | PubMed |
| 17393325 | The anti-cancer effect of COX-2 inhibitors on gastric cancer cells. | Dig Dis Sci | 2007 | https://conductscience.org/library/papers/17393325 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15530895
GET https://conductscience.org/api/papers/v1/15530895/cited_by?page=2